Mechanism-based small molecule probes for labeling CD38 on live cells

Area of Science:

• Biochemistry
• Cell Biology
• Immunology

Background:

• CD38 is a type II transmembrane glycoprotein with dual ecto-enzyme and receptor functions.
• Its enzymatic activity produces calcium-releasing agents (cADPR, NAADP), while receptor function impacts immune cell signaling and cytokine production.
• CD38 is implicated in hormone secretion, immune cell differentiation, and immune responses, and serves as a negative prognostic marker in chronic lymphatic leukemia (CLL).

Purpose of the Study:

• To develop a mechanism-based method for fluorescently labeling CD38 on live cells.
• To enable detailed investigation of CD38's physiological and pathological roles at cellular and molecular levels.
• To provide a tool for dissecting CD38's receptor function independently of its enzymatic activity.

Main Methods:

• A novel mechanism-based fluorescent labeling strategy was employed for CD38.
• The method was validated for its compatibility with live-cell imaging.
• Assessment of the labeling method's impact on CD38 receptor function and downstream signaling was performed.

Main Results:

• A fluorescent labeling method for CD38 on live cells was successfully established.
• The labeling technique does not impede CD38's receptor function or downstream signaling pathways.
• The method also inhibits CD38's enzymatic activity, allowing for isolated study of its receptor function.

Conclusions:

• The developed fluorescent labeling method is a valuable tool for studying CD38 receptor function in live cells.
• This technique facilitates a deeper understanding of CD38's role in both normal biological processes and disease states like CLL.
• The ability to selectively inhibit enzymatic activity while preserving receptor function opens new avenues for mechanistic studies of CD38.